Skip to main content

Table 5 Serum concentrations of glucose, triacylglycerol (TAG) and lactate, and liver glycogen content of non-tumor (prefix C), and Walker 256 tumor-bearing rats (prefix W)

From: Antitumor and anti-cachectic effects of shark liver oil and fish oil: comparison between independent or associative chronic supplementation in Walker 256 tumor-bearing rats

 Groups Glucose (mg/dL) TAG (mg/dL) Lactate (mmol/L) Liver Glycogen (μmol/g tissue) (w/w)
C 97.4 ± 3.2 67.4 ± 3.4 1.28 ± 0.1 137.5 ± 5.9
CSLO 96.8 ± 2.2 71.8 ± 3.8 1.27 ± 0.1 137.7 ± 5.5
CFO 98.7 ± 3.3 63.2 ± 6.1 1.39 ± 0.1 156.8 ± 7.2
CSLO + FO 94.9 ± 2.3 66.9 ± 3.2 1.27 ± 0.1 148.5 ± 8.4
W 78.7 ± 1.5a 113.4 ± 9.4a 2.26 ± 0.1a 94.5 ± 9.8a
WSLO 87.9 ± 2.5b 92.3 ± 4.4 1.47 ± 0.1b 124.7 ± 2.3b
WFO 99.9 ± 3.9b 78.9 ± 4.7b 1.5 ± 0.1b 125.2 ± 5.6ab
WSLO + FO 94.4 ± 2.3b 83.8 ± 4.6b 1.43 ± 0.1b 125.4 ± 3.5ab
  1. Rats fed regular chow (C and W), supplemented with SLOil (CSLO and WSLO), FOil (CFO and WFO) and both (CSLO + FO and WSLO + FO). Data are presented as mean ± SEM of 4 independent experiments of 5 rats per group (n = 20). ap < 0.01 compared to respective group without tumor; bp < 0.05 compared to W group.